Christine Petit
Paris, 75005, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 116 publications
Erratum: Efficacy and safety of SENS-501, a dual-AAV otoferlin gene therapy, for DFNB9 congenital deafness.
Journal: Molecular therapy. Advances
Published: August 07, 2026
Genetics of prelingual isolated deafness and Usher syndrome in the Maghreb and Jordan: Harnessing the potential of homozygosity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 08, 2025
Efficacy and safety of SENS-501, a dual-AAV otoferlin gene therapy, for DFNB9 congenital deafness.
Journal: Molecular therapy. Advances
Published: December 04, 2025
Bridging the gap between physics and biology of hearing: Timing and amplification.
Journal: Current opinion in neurobiology
Published: August 21, 2025
Genetic diversity of Usher syndrome in Moroccan patients.
Journal: Human genetics
Published: November 20, 2024
Cochlear gene therapy restores hearing and auditory processing in an atypical DFNB9 mouse model.
Journal: Communications medicine
Published: September 24, 2024
Deciphering Auditory Hyperexcitability in Otogl Mutant Mice Unravels an Auditory Neuropathy Mechanism.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 04, 2024
Corrigendum: Current phenotypic and genetic spectrum of syndromic deafness in Tunisia: paving the way for precision auditory health.
Journal: Frontiers in genetics
Published: May 23, 2024
Exome sequencing reveals pathogenic mutations in the LARS2 and HSD17B4 genes associated with Perrault syndrome and D-bifunctional protein deficiency in Moroccan families.
Journal: Molecular biology reports
Published: April 25, 2024
A free intravesicular C-terminal of otoferlin is essential for synaptic vesicle docking and fusion at auditory inner hair cell ribbon synapses.
Journal: Progress in neurobiology
Published: March 21, 2024
Last Updated: 09/26/2026